Hypoxia Inducible Factor 1: A Urinary Biomarker of Kidney Disease

Clinical and Translational Science

Volumn 10, Issue 3, 2017, Pages 201-207

  Movafagh, S ^a   Raj, D ^b   Sanaei Ardekani, M ^c   Bhatia, D ^a   Vo, K ^a   Mahmoudieh, M ^a   Rahman, R ^c   Kim, E H ^c   Harralson, A F ^a  

^a SHENANDOAH UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c Kidney and Hypertension Specialists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CADHERIN; CADHERIN 16; CREATININE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; UNCLASSIFIED DRUG; HAVCR1 PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1; KIDNEY INJURY MOLECULE 1;

ACTB GENE; AGED; ARTICLE; B2M GENE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GAPDH GENE; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCATION; HIF 1ALPHA GENE; HUMAN; KIDNEY CELL; MALE; PES1 GENE; POLR2A GENE; PROTEIN EXPRESSION; RNA ISOLATION; UBC GENE; ADULT; BLOOD; DEMOGRAPHY; ESSENTIAL GENE; GENETICS; KIDNEY; METABOLISM; STANDARD; URINE;

ADULT; AGED; BIOMARKERS; CADHERINS; CREATININE; DEMOGRAPHY; FEMALE; GENES, ESSENTIAL; HEPATITIS A VIRUS CELLULAR RECEPTOR 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY; MALE; REFERENCE STANDARDS; RENAL INSUFFICIENCY, CHRONIC; RNA, MESSENGER;

EID: 85012897762     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/cts.12445     Document Type: Article

References (33)

1. Eckardt, K.-U., Rosenberger, C., Jürgensen, J.S. & Wiesener, M.S. Role of hypoxia in the pathogenesis of renal disease. Blood Purif. 21, 253–257 (2003).
2. Nangaku, M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J. Am. Soc. Nephrol. JASN. 17, 17–25 (2006).
3. Semenza, G.L. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda MD) 19, 176–182 (2004).
4. Ratcliffe, P.J., O'Rourke, J.F., Maxwell, P.H. & Pugh, C.W. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J. Exp. Biol. 201, 1153–1162 (1998).
5. Deng, A. et al. Renal protection in chronic kidney disease: hypoxia-inducible factor activation vs. angiotensin II blockade. Am. J. Physiol. Renal Physiol. 299, F1365–F1373 (2010).
6. Nangaku, M. & Eckardt, K.-U. Hypoxia and the HIF system in kidney disease. J. Mol. Med. (Berlin) 85, 1325–1330 (2007).
7. Gunaratnam, L. & Bonventre, J.V. HIF in kidney disease and development. J. Am. Soc. Nephrol. JASN. 20, 1877–1887 (2009).
8. Tanaka, T. & Nangaku, M. Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKD. J. Pharmacol. Sci. 109, 24–31 (2009).
9. Uchida, T. et al. Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha. J. Biol. Chem. 279, 14871–14878 (2004).
10. Maxwell, P.H. & Eckardt, K.-U. HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond. Nat. Rev. Nephrol. 12, 157–168 (2016).
11. Du, J. et al. Combination of HIF-1α gene transfection and HIF-1-activated bone marrow-derived angiogenic cell infusion improves burn wound healing in aged mice. Gene Ther. 20, 1070–1076 (2013).
12. Maxwell, P. HIF-1: an oxygen response system with special relevance to the kidney. J. Am. Soc. Nephrol. 14, 2712–2722 (2003).
13. Li, B. et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N. Engl. J. Med. 344, 947–954 (2001).
14. Matz, M. et al. Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. Kidney Int. 69, 1683–1690 (2006).
15. Guo, B., Luo, C., Xun, C., Xie, J., Wu, X. & Pu, J. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR. Exp. Oncol. 31, 43–47 (2009).
16. Szeto, C.-C. et al. Urinary expression of kidney injury markers in renal transplant recipients. Clin. J. Am. Soc. Nephrol. 5, 2329–2337 (2010).
17. Vandesompele, J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 (2002):RESEARCH0034.
18. Schmittgen, T.D. & Livak, K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101–1108 (2008).
19. Coca, S.G. & Parikh, C.R. Urinary biomarkers for acute kidney injury: perspectives on translation. Clin. J. Am. Soc. Nephrol. CJASN. 3, 481–90 (2008).
20. Thomson, R.B. et al. Isolation and cDNA cloning of Ksp-cadherin, a novel kidney-specific member of the cadherin multigene family. J. Biol. Chem. 270, 17594–17601 (1995).
21. Morizane, R. et al. Kidney specific protein-positive cells derived from embryonic stem cells reproduce tubular structures in vitro and differentiate into renal tubular cells. PLoS One 8, e64843 (2013).
22. Palazón, A., Aragonés, J., Morales-Kastresana, A., Landázuri, M.O. & de Melero, I. Molecular pathways: hypoxia response in immune cells fighting or promoting cancer. Clin Cancer Res. 18, 1207–1213 (2012)
23. Song, Y.S., Lee, H.J., Doo, S.W., An, J. & Kim, S.U. Enhanced angiogenesis and relaxation of bladder as early response to bladder outlet obstruction. Int. J. Urol. 20, 116–122 (2013).
24. Palit, V., Phillips, R.M., Puri, R., Shah, T. & Bibby, M.C. Expression of HIF-1alpha and Glut-1 in human bladder cancer. Oncol. Rep. 14, 909–913 (2005).
25. Weidemann, A. et al. HIF activation protects from acute kidney injury. J. Am. Soc. Nephrol. 19, 486–494 (2008).
26. Rosenberger, C. et al. Up-regulation of HIF in experimental acute renal failure: evidence for a protective transcriptional response to hypoxia. Kidney Int. 67, 531–542 (2005)
27. Manotham, K. et al. Evidence of tubular hypoxia in the early phase in the remnant kidney model. J. Am. Soc. Nephrol. 15, 1277–1288 (2004).
28. Wolf, G., Schroeder, R. & Stahl, R.A.K. Angiotensin II induces hypoxia-inducible factor-1 alpha in PC 12 cells through a posttranscriptional mechanism: role of AT2 receptors. Am. J. Nephrol. 24, 415–421 (2004).
29. Tesch, G.H. Review: Serum and urine biomarkers of kidney disease: A pathophysiological perspective. Nephrology 15, 609–616 (2010).
30. Schena, F.P., Serino, G. & Sallustio, F. MicroRNAs in kidney diseases. New promising biomarkers for diagnosis and monitoring. Nephrol. Dial. Transplant. 29, 755–763 (2014).
31. Wei, Q., Bhatt, K., He, H.-Z., Mi, Q.-S., Haase, V.H. & Dong, Z. Targeted deletion of dicer from proximal tubules protects against renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 21, 756–761 (2010).
32. Movafagh, S., Crook, S. & Vo, K. Regulation of hypoxia-inducible factor-1a by reactive oxygen species: new developments in an old debate. J. Cell Biochem. 116, 696–703 (2015).
33. Crosby, M.E., Devlin, C.M., Glazer, P.M., Calin, G.A. & Ivan, M. Emerging roles of microRNAs in the molecular responses to hypoxia. Curr. Pharm. Des. 15, 3861–3866 (2009).